KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Change in Acquisitions & Divestments: 2009-2024

Historic Change in Acquisitions & Divestments for Sarepta Therapeutics (SRPT) over the last 12 years, with Dec 2024 value amounting to $2.0 billion.

  • Sarepta Therapeutics' Change in Acquisitions & Divestments fell 70.94% to $86.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 25.82%. This contributed to the annual value of $2.0 billion for FY2024, which is 7.15% up from last year.
  • Sarepta Therapeutics' Change in Acquisitions & Divestments amounted to $2.0 billion in FY2024, which was up 7.15% from $1.9 billion recorded in FY2023.
  • Over the past 5 years, Sarepta Therapeutics' Change in Acquisitions & Divestments peaked at $2.0 billion during FY2024, and registered a low of $466.0 million during FY2021.
  • Over the past 3 years, Sarepta Therapeutics' median Change in Acquisitions & Divestments value was $1.9 billion (recorded in 2023), while the average stood at $1.6 billion.
  • Per our database at Business Quant, Sarepta Therapeutics' Change in Acquisitions & Divestments crashed by 60.82% in 2021 and then skyrocketed by 102.39% in 2023.
  • Over the past 5 years, Sarepta Therapeutics' Change in Acquisitions & Divestments (Yearly) stood at $1.2 billion in 2020, then slumped by 60.82% to $466.0 million in 2021, then skyrocketed by 98.12% to $923.2 million in 2022, then skyrocketed by 102.39% to $1.9 billion in 2023, then increased by 7.15% to $2.0 billion in 2024.